journal article·2022-10Open access

Antihypertension Nanoblockers Increase Intratumoral Perfusion of Sequential Cytotoxic Nanoparticles to Enhance Chemotherapy Efficacy against Pancreatic Cancer

Suchen Bian, Haijiang Dong, Long Zhao, Zequn Li, Jian Chen, Xingxin Zhu, Nasha Qiu, Xing Jia, Wenfeng Song, Zekuan Li, Shusen Zheng, Hangxiang Wang, Penghong Song

Advanced Science· Volume 9· Issue 29

Abstract

Abstract Pancreatic ductal adenocarcinoma (PDAC), one of the worst prognosis types of tumors, is characterized by dense extracellular matrix, which compresses tumor vessels and forms a physical barrier to inhibit therapeutic drug penetration and efficacy. Herein, losartan, an antihypertension agent, is applied as a tumor stroma modulator and developed into a nanosystem. A series of lipophilic losartan prodrugs are constructed by esterification of the hydroxyl group on losartan to fatty acids. Based on the self‐assembly ability and hydrodynamic diameter, the losartan‐linoleic acid conjugate is selected for further investigation. To improve the stability in vivo, nanoassemblies are refined with PEGylation to form losartan nanoblocker (Los NB), and administered via intravenous injection for experiments. On murine models of pancreatic cancer, Los NB shows a greater ability to remodel the tumor microenvironment than free losartan, including stromal depletion, vessel perfusion increase, and hypoxia relief. Furthermore, Los NB pretreatment remarkably enhances the accumulation and penetration of 7‐ethyl‐10‐hydroxycamptothecin (SN38)‐loaded nanodrugs (SN38 NPs) in tumor tissues. Expectedly, overall therapeutic efficacy of SN38 NPs is significantly enhanced after Los NB pretreatment. Since losartan is one of the most commonly used antihypertension agents, this study may provide a potential for clinical transformation in stroma‐rich PDAC treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer, Hypoxia, and Metabolism · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Hepatobiliary and Pancreatic Surgery Department of Surgery The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310003 China

NHC Key Laboratory of Combined Multi‐organ Transplantation Hangzhou 310003 China

Key Laboratory of the diagnosis and treatment of Organ Transplantation Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer Chinese Academy of Medical Sciences (2019RU019) Hangzhou 310003 China

Key Laboratory of Organ Transplantation Research Center for Diagnosis and Treatment of Hepatobiliary Diseases Hangzhou Zhejiang Province 310003 China

Department of Hepatobiliary and Pancreatic Surgery The Center for Integrated Oncology and Precision Medicine Affiliated Hangzhou First People's Hospital Zhejiang University School of Medicine Hangzhou 310006 China

Funding

National Natural Science Foundation of China · Health Commission of Zhejiang Province

References (61)

Show source-provided references
1. 10.1038/nrdp.2016.2210.1038/nrdp.2016.22 ↗
2. 10.1016/S0140-6736(20)30974-010.1016/S0140-6736(20)30974-0 ↗
3. 10.1056/NEJMra140419810.1056/NEJMra1404198 ↗
4. 10.1038/nrgastro.2012.11510.1038/nrgastro.2012.115 ↗
5. 10.1016/j.pharmthera.2012.10.00310.1016/j.pharmthera.2012.10.003 ↗
6. 10.1136/gutjnl-2018-31645110.1136/gutjnl-2018-316451 ↗
7. 10.1016/j.addr.2018.06.01410.1016/j.addr.2018.06.014 ↗
8. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
9. 10.1021/acsnano.5b0778110.1021/acsnano.5b07781 ↗
10. 10.1021/ja312004m10.1021/ja312004m ↗
11. 10.1021/acsnano.5b0051010.1021/acsnano.5b00510 ↗
12. 10.1016/j.canlet.2016.12.03510.1016/j.canlet.2016.12.035 ↗
13. Chen Y. · ACS Nano · 2019 · 13 · 1751
14. 10.1021/acsnano.7b0152210.1021/acsnano.7b01522 ↗
15. 10.1073/pnas.101889210810.1073/pnas.1018892108 ↗
16. 10.1016/j.actbio.2015.12.00210.1016/j.actbio.2015.12.002 ↗
17. 10.1038/ncomms351610.1038/ncomms3516 ↗
18. 10.1007/s13346-018-00610-110.1007/s13346-018-00610-1 ↗
19. 10.1002/adfm.20150195310.1002/adfm.201501953 ↗
20. 10.1016/j.biomaterials.2021.12070510.1016/j.biomaterials.2021.120705 ↗
21. 10.1021/acsami.7b0193810.1021/acsami.7b01938 ↗
22. 10.1158/0008-5472.CAN-17-098410.1158/0008-5472.CAN-17-0984 ↗
23. 10.1002/anie.20140668510.1002/anie.201406685 ↗
24. 10.1021/acsami.9b1620910.1021/acsami.9b16209 ↗
25. 10.1126/science.125528810.1126/science.1255288 ↗
26. 10.1021/la900310k10.1021/la900310k ↗
27. 10.1038/nnano.2011.16610.1038/nnano.2011.166 ↗
28. 10.1038/s41467-019-09007-110.1038/s41467-019-09007-1 ↗
29. 10.1021/jp067011k10.1021/jp067011k ↗
30. 10.1053/j.gastro.2017.03.04610.1053/j.gastro.2017.03.046 ↗
31. 10.1016/S0002-9440(10)61125-X10.1016/S0002-9440(10)61125-X ↗
32. 10.1053/j.gastro.2004.12.03610.1053/j.gastro.2004.12.036 ↗
33. 10.1038/s41598-018-21600-w10.1038/s41598-018-21600-w ↗
34. 10.1038/nm.385310.1038/nm.3853 ↗
35. 10.1016/j.cell.2015.08.06810.1016/j.cell.2015.08.068 ↗
36. 10.1158/1078-0432.CCR-06-011310.1158/1078-0432.CCR-06-0113 ↗
37. 10.1136/gutjnl-2015-30930410.1136/gutjnl-2015-309304 ↗
38. 10.1152/ajprenal.00139.200310.1152/ajprenal.00139.2003 ↗
39. 10.1016/j.ceb.2010.08.01510.1016/j.ceb.2010.08.015 ↗
40. 10.1016/j.jconrel.2015.03.02310.1016/j.jconrel.2015.03.023 ↗
41. 10.1038/ncb315710.1038/ncb3157 ↗
42. 10.1073/pnas.121335310910.1073/pnas.1213353109 ↗
43. 10.1126/science.117136210.1126/science.1171362 ↗
44. 10.1016/j.ccell.2014.10.00610.1016/j.ccell.2014.10.006 ↗
45. 10.3748/wjg.v20.i28.947610.3748/wjg.v20.i28.9476 ↗
46. 10.1136/gut.2006.10862110.1136/gut.2006.108621 ↗
47. 10.1002/ijc.2539910.1002/ijc.25399 ↗
48. Pan L. · Am. J. Cancer Res. · 2019 · 9 · 562
49. 10.1038/nrclinonc.2018.2910.1038/nrclinonc.2018.29 ↗
50. 10.1126/sciimmunol.aat148210.1126/sciimmunol.aat1482 ↗
51. 10.1101/cshperspect.a02853010.1101/cshperspect.a028530 ↗
52. 10.1182/blood-2011-04-32522510.1182/blood-2011-04-325225 ↗
53. 10.1021/acsnano.5b0201710.1021/acsnano.5b02017 ↗
54. 10.1038/nrclinonc.2009.23610.1038/nrclinonc.2009.236 ↗
55. 10.1016/j.cell.2009.11.00710.1016/j.cell.2009.11.007 ↗
56. 10.1158/1078-0432.CCR-13-145510.1158/1078-0432.CCR-13-1455 ↗
57. 10.1038/s41575-020-0300-110.1038/s41575-020-0300-1 ↗
58. 10.1186/s12943-018-0927-510.1186/s12943-018-0927-5 ↗
59. 10.1073/pnas.131912311010.1073/pnas.1319123110 ↗
60. 10.1016/j.bcp.2008.07.00610.1016/j.bcp.2008.07.006 ↗
61. 10.1016/S1499-3872(12)60230-610.1016/S1499-3872(12)60230-6 ↗